Assessment of Hyperosmolar Blood–Brain Barrier Opening in Glioblastoma via Histology with Evans Blue and DCE-MRI
Open Access
- 11 July 2023
- journal article
- research article
- Published by MDPI AG in Biomedicines
- Vol. 11 (7) , 1957
Abstract
Background: While the blood–brain barrier (BBB) is often compromised in glioblastoma (GB), the perfusion and consequent delivery of drugs are highly heterogeneous. Moreover, the accessibility of drugs is largely impaired in the margins of the tumor and for infiltrating cells at the origin of tumor recurrence. In this work, we evaluate the value of methods to assess hemodynamic changes induced by a hyperosmolar shock in the core and the margins of a tumor in a GB model. Methods: Osmotic shock was induced with an intracarotid infusion of a hypertonic solution of mannitol in mice grafted with U87-MG cells. The distribution of fluorescent dye (Evans blue) within the brain was assessed via histology. Dynamic contrast-enhanced (DCE)-MRI with an injection of Gadolinium-DOTA as the contrast agent was also used to evaluate the effect on hemodynamic parameters and the diffusion of the contrast agent outside of the tumor area. Results: The histological study revealed that the fluorescent dye diffused much more largely outside of the tumor area after osmotic shock than in control tumors. However, the study of tumor hemodynamic parameters via DCE-MRI did not reveal any change in the permeability of the BBB, whatever the studied MRI parameter. Conclusions: The use of hypertonic mannitol infusion seems to be a promising method to increase the delivery of compounds in the margins of GB. Nevertheless, the DCE-MRI analysis method using gadolinium-DOTA as a contrast agent seems of limited value for determining the efficacy of opening the BBB in GB after osmotic shock.Keywords
Funding Information
- FNRS-Télévie (7.4620.19, 7.6505.21)
This publication has 51 references indexed in Scilit:
- Classic models for dynamic contrast‐enhanced MRINMR in Biomedicine, 2013
- On the scope and interpretation of the Tofts models for DCE‐MRIMagnetic Resonance in Medicine, 2011
- Heterogeneous Blood–Tumor Barrier Permeability Determines Drug Efficacy in Experimental Brain Metastases of Breast CancerClinical Cancer Research, 2010
- Impaired blood–brain and blood–spinal cord barriers in mutant SOD1-linked ALS ratBrain Research, 2009
- REAL-TIME MONITORING OF GADOLINIUM DIETHYLENETRIAMINE PENTA-ACETIC ACID DURING OSMOTIC BLOOD-BRAIN BARRIER DISRUPTION USING MAGNETIC RESONANCE IMAGING IN NORMAL WISTAR RATSNeurosurgery, 2009
- A new method for determining blood–brain barrier integrity based on intracardiac perfusion of an Evans Blue–Hoechst cocktailJournal of Neuroscience Methods, 2008
- Effect of anesthesia on the signal intensity in tumors using BOLD-MRI: Comparison with flow measurements by Laser Doppler flowmetry and oxygen measurements by luminescence-based probesMagnetic Resonance Imaging, 2004
- Advances in osmotic opening of the blood-brain barrier to enhance CNS chemotherapyExpert Opinion on Investigational Drugs, 2001
- Gadolinium Chelates with Weak Binding to Serum ProteinsInvestigative Radiology, 1997
- Gd-DTPA MR Detection of Blood-Brain Barrier Opening in Rats after Hyperosmotic ShockJournal of Computer Assisted Tomography, 1993